Exact Mass: 643.4726098
Exact Mass Matches: 643.4726098
Found 381 metabolites which its exact mass value is equals to given mass value 643.4726098,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
GlcCer(d18:1/12:0)
GlcCer(d18:1/12:0) is a glycosphingolipid (ceramide and oligosaccharide)or oligoglycosylceramide with one or more sialic acids (i.e. n-acetylneuraminic acid) linked on the sugar chain. It is a component the cell plasma membrane which modulates cell signal transduction events. Gangliosides have been found to be highly important in immunology. Ganglioside GL1a carries a net-negative charge at pH 7.0 and is acidic. Gangliosides can amount to 6\\% of the weight of lipids from brain, but they are found at low levels in all animal tissues.Cerebrosides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Cerebrosides have a single sugar group linked to ceramide. The most common are galactocerebrosides (containing galactose), the least common are glucocerebrosides (containing glucose). Galactocerebrosides are found predominantly in neuronal cell membranes. In contrast glucocerebrosides are not normally found in membranes. Instead, they are typically intermediates in the synthesis or degradation of more complex glycosphingolipids. Galactocerebrosides are synthesized from ceramide and UDP-galactose. Excess lysosomal accumulation of glucocerebrosides is found in Gaucher disease. A glycosphingolipid (ceramide and oligosaccharide)or oligoglycosylceramide with one or more sialic acids (i.e. n-acetylneuraminic acid) linked on the sugar chain. It is a component the cell plasma membrane which modulates cell signal transduction events. Gangliosides have been found to be highly important in immunology. Ganglioside GL1a carries a net-negative charge at pH 7.0 and is acidic. Gangliosides can amount to 6\\% of the weight of lipids from brain, but they are found at low levels in all animal tissues.
Galactosylceramide (d18:1/12:0)
Galactosylceramide (GalCer) is a non-acidic monoglycosphingolipid, i.e. a sphingolipid with one carbohydrate moiety attached to a ceramide unit. It is an intermediate in sphingolipid metabolism and is the second to last step in the synthesis of digalactosylceramidesulfate. GalCer is generated from ceramide via the enzyme UDP-galactose ceramide galactosyltransferase [EC:2.4.1.47]. It can be converted to digalactosylceramide via the enzyme glycosyltransferases [EC 2.4.1.-]. Galactosylceramide is the principal glycosphingolipid in brain tissue, hence the trivial name "cerebroside", which was first conferred on it in 1874. Galactosylceramides are found in all nervous tissues, but they can amount to 2\\% of the dry weight of grey matter and 12\\% of white matter. They are major constituents of oligodendrocytes. Synthesis of galactosylceramide takes place on the lumenal surface of the endoplasmic reticulum, although it has free access to the cytosolic surface by an energy-independent flip-flop process. GalCer sits in the extracellular leaflet of cell membranes in nanometer sized domains or rafts. The local clustering of GalCer within rafts is thought to facilitate the initial adhesion of certain viruses, including HIV-1 and bacteria to cells through multivalent interactions between receptor proteins and GalCer. A defect in the degradation of cerbrosides leads to a disorder called Krabbe disease. Krabbe disease (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare, often fatal degenerative disorder that affects the myelin sheath of the nervous system. Krabbe disease is caused by mutations in the GALC gene, which causes a deficiency of galactosylceramidase. Infants with Krabbe disease are normal at birth. Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures, feeding difficulties, vomiting, and slowing of mental and motor development. There are also juvenile- and adult-onset cases of Krabbe disease, which have similar symptoms but slower progression. In infants, the disease is generally fatal before age 2. Patients with late-onset Krabbe disease tend to have a slower progression of the disease and live significantly longer.Cerebrosides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Cerebrosides have a single sugar group linked to ceramide. The most common are galactocerebrosides (containing galactose), the least common are glucocerebrosides (containing glucose). Galactocerebrosides are found predominantly in neuronal cell membranes. In contrast glucocerebrosides are not normally found in membranes. Instead, they are typically intermediates in the synthesis or degradation of more complex glycosphingolipids. Galactocerebrosides are synthesized from ceramide and UDP-galactose. Excess lysosomal accumulation of glucocerebrosides is found in Gaucher disease. Galactosylceramide (GalCer) is a non-acidic monoglycosphingolipid, i.e. a sphingolipid with one carbohydrate moiety attached to a ceramide unit. It is an intermediate in sphingolipid metabolism and is the second to last step in the synthesis of digalactosylceramidesulfate. GalCer is generated from ceramide via the enzyme UDP-galactose ceramide galactosyltransferase [EC:2.4.1.47]. It can be converted to digalactosylceramide via the enzyme glycosyltransferases [EC 2.4.1.-]. Galactosylceramide is the principal glycosphingolipid in brain tissue, hence the trivial name "cerebroside", which was first conferred on it in 1874. Galactosylceramides are found in all nervous tissues, but they can amount to 2\\% of the dry weight of grey matter and 12\\% of white matter. They are major constituents of oligodendrocytes. Synthesis of galactosylceramide takes place on the lumenal surface of the endoplasmic reticulum, although it has free access to the cytosolic surface by an energy-independent flip-flop process. GalCer sits in the extracellular leaflet of cell membranes in nanometer sized domains or rafts. The local clustering of GalCer within rafts is thought to facilitate the initial adhesion of certain viruses, including HIV-1 and bacteria to cells through multivalent interactions between receptor proteins and GalCer. A defect in the degradation of cerbrosides leads to a disorder called Krabbe disease. Krabbe disease (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare, often fatal degenerative disorder that affects the myelin sheath of the nervous system. Krabbe disease is caused by mutations in the GALC gene, which causes a deficiency of galactosylceramidase. Infants with Krabbe disease are normal at birth. Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures, feeding difficulties, vomiting, and slowing of mental and motor development. There are also juvenile- and adult-onset cases of Krabbe disease, which have similar symptoms but slower progression. In infants, the disease is generally fatal before age 2. Patients with late-onset Krabbe disease tend to have a slower progression of the disease and live significantly longer.
Cer(d18:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))
Cer(d18:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).
Cer(d18:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))
Cer(d18:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).
Cer(d20:1/PGJ2)
Cer(d20:1/PGJ2) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).
Cer(t18:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))
Cer(t18:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).
Cer(t18:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))
Cer(t18:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).
Cer(t18:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))
Cer(t18:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).
Cer(t18:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))
Cer(t18:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).
Cer(t18:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))
Cer(t18:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).
3-methoxy-4-hydroxy-5-all-trans-heptaprenylbenzoate
3-methoxy-4-hydroxy-5-all-trans-heptaprenylbenzoate, also known as 3-heptaprenyl-4-hydroxy-5-methoxybenzoate, is a member of the class of compounds known as sesquaterpenoids. Sesquaterpenoids are terpenoids with at least 7 consecutive isoprene units. 3-methoxy-4-hydroxy-5-all-trans-heptaprenylbenzoate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 3-methoxy-4-hydroxy-5-all-trans-heptaprenylbenzoate can be found in a number of food items such as annual wild rice, breadfruit, bilberry, and mulberry, which makes 3-methoxy-4-hydroxy-5-all-trans-heptaprenylbenzoate a potential biomarker for the consumption of these food products.
24-O-Desulfo-26-sulfooxysqualamine
C34H65N3O6S (643.4593830000001)
12alpha-hydroxy-squalamine
C34H65N3O6S (643.4593830000001)
(2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate
C35H66NO7P (643.4576655999999)
beta-D-galactosyl-N-(dodecanoyl)sphingosine
A D-galactosyl-N-acylsphingosine in which the ceramide N-acyl group is dodecanoyl.
3-methoxy-4-hydroxy-5-all-trans-heptaprenylbenzoate
Cer(d18:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))
Cer(d18:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))
N-oleoylsphingosine 1-phosphate
C36H70NO6P (643.4940489999999)
An N-acylsphingosine 1-phosphate in which the N-acyl group is specified as oleoyl.
N-octadecanoylsphingosine 1-phosphate(2-)
C36H70NO6P-2 (643.4940489999999)
[(E,2S,3R)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]octadec-4-enyl] dihydrogen phosphate
C36H70NO6P (643.4940489999999)
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (16Z,19Z,22Z)-triaconta-16,19,22-trienoate
C35H66NO7P (643.4576655999999)
[3-nonoxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C35H66NO7P (643.4576655999999)
2-(2-Heptadecanoyloxy-3-nonanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-(2-Octadecanoyloxy-3-octanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-[2,3-Di(tridecanoyloxy)propoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-(3-Dodecanoyloxy-2-tetradecanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-(2-Pentadecanoyloxy-3-undecanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate
2-(3-Decanoyloxy-2-hexadecanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate
(E)-3-hydroxy-2-[[(Z)-2-hydroxypentacos-11-enoyl]amino]undec-4-ene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(4E,8E)-3-hydroxy-2-(2-hydroxyheptadecanoylamino)nonadeca-4,8-diene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(E)-3-hydroxy-2-[[(Z)-2-hydroxynonadec-9-enoyl]amino]heptadec-4-ene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propan-2-yl] hexanoate
C35H66NO7P (643.4576655999999)
(E)-3-hydroxy-2-[[(Z)-2-hydroxyoctadec-11-enoyl]amino]octadec-4-ene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]propan-2-yl] acetate
C35H66NO7P (643.4576655999999)
(E)-3-hydroxy-2-[[(Z)-2-hydroxytricos-11-enoyl]amino]tridec-4-ene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(4E,8E)-3-hydroxy-2-(2-hydroxyhexadecanoylamino)icosa-4,8-diene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(E)-3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]docos-4-ene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
3-hydroxy-2-[[(4Z,7Z)-2-hydroxyhexadeca-4,7-dienoyl]amino]icosane-1-sulfonic acid
C36H69NO6S (643.4845333999999)
3-hydroxy-2-[[(18Z,21Z)-2-hydroxytetracosa-18,21-dienoyl]amino]dodecane-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(E)-3-hydroxy-2-[[(Z)-2-hydroxyhexacos-11-enoyl]amino]dec-4-ene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(E)-3-hydroxy-2-[[(Z)-2-hydroxydocos-11-enoyl]amino]tetradec-4-ene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
3-hydroxy-2-[[(10Z,12Z)-2-hydroxyoctadeca-10,12-dienoyl]amino]octadecane-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(E)-3-hydroxy-2-[[(Z)-2-hydroxypentadec-9-enoyl]amino]henicos-4-ene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(4E,8E)-3-hydroxy-2-(2-hydroxytricosanoylamino)trideca-4,8-diene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]tetracos-4-ene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(E)-3-hydroxy-2-[[(Z)-2-hydroxyhexadec-7-enoyl]amino]icos-4-ene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(4E,8E)-3-hydroxy-2-(2-hydroxyhenicosanoylamino)pentadeca-4,8-diene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(4E,8E)-3-hydroxy-2-(2-hydroxyoctadecanoylamino)octadeca-4,8-diene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
3-hydroxy-2-[[(11Z,14Z)-2-hydroxyhexacosa-11,14-dienoyl]amino]decane-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(4E,8E)-3-hydroxy-2-(2-hydroxytetracosanoylamino)dodeca-4,8-diene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(E)-3-hydroxy-2-[[(Z)-2-hydroxyhenicos-9-enoyl]amino]pentadec-4-ene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(4E,8E)-3-hydroxy-2-(2-hydroxytetradecanoylamino)docosa-4,8-diene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate
C35H66NO7P (643.4576655999999)
(E)-3-hydroxy-2-[[(Z)-2-hydroxytetracos-11-enoyl]amino]dodec-4-ene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]tricos-4-ene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
3-hydroxy-2-[[(14Z,16Z)-2-hydroxydocosa-14,16-dienoyl]amino]tetradecane-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(4E,8E)-3-hydroxy-2-(2-hydroxynonadecanoylamino)heptadeca-4,8-diene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(4E,8E)-3-hydroxy-2-(2-hydroxyicosanoylamino)hexadeca-4,8-diene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(4E,8E)-3-hydroxy-2-(2-hydroxydocosanoylamino)tetradeca-4,8-diene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(4E,8E)-3-hydroxy-2-(2-hydroxypentadecanoylamino)henicosa-4,8-diene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(4E,8E)-3-hydroxy-2-(2-hydroxytridecanoylamino)tricosa-4,8-diene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(E)-3-hydroxy-2-[[(Z)-2-hydroxyicos-11-enoyl]amino]hexadec-4-ene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
(4E,8E)-3-hydroxy-2-(2-hydroxydodecanoylamino)tetracosa-4,8-diene-1-sulfonic acid
C36H69NO6S (643.4845333999999)
3-hydroxy-2-[[(11Z,14Z)-2-hydroxyicosa-11,14-dienoyl]amino]hexadecane-1-sulfonic acid
C36H69NO6S (643.4845333999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]propan-2-yl] butanoate
C35H66NO7P (643.4576655999999)
[2-propanoyloxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C35H66NO7P (643.4576655999999)
3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]tricosane-1-sulfonic acid
C37H73NO5S (643.5209167999999)
(E)-2-(henicosanoylamino)-3-hydroxyhexadec-4-ene-1-sulfonic acid
C37H73NO5S (643.5209167999999)
(E)-3-hydroxy-2-(tricosanoylamino)tetradec-4-ene-1-sulfonic acid
C37H73NO5S (643.5209167999999)
(E)-2-(dodecanoylamino)-3-hydroxypentacos-4-ene-1-sulfonic acid
C37H73NO5S (643.5209167999999)
(4E,8E,12E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxyhexadeca-4,8,12-triene-1-sulfonic acid
2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyicosane-1-sulfonic acid
C37H73NO5S (643.5209167999999)
(E)-2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]amino]-3-hydroxydodec-4-ene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]octadeca-4,8,12-triene-1-sulfonic acid
(E)-3-hydroxy-2-(nonadecanoylamino)octadec-4-ene-1-sulfonic acid
C37H73NO5S (643.5209167999999)
(E)-3-hydroxy-2-(icosanoylamino)heptadec-4-ene-1-sulfonic acid
C37H73NO5S (643.5209167999999)
2-[[(Z)-docos-13-enoyl]amino]-3-hydroxypentadecane-1-sulfonic acid
C37H73NO5S (643.5209167999999)
2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyhenicosane-1-sulfonic acid
C37H73NO5S (643.5209167999999)
(E)-3-hydroxy-2-(octadecanoylamino)nonadec-4-ene-1-sulfonic acid
C37H73NO5S (643.5209167999999)
3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]tetracosane-1-sulfonic acid
C37H73NO5S (643.5209167999999)
(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]tetradeca-4,8,12-triene-1-sulfonic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
C35H66NO7P (643.4576655999999)
(E)-3-hydroxy-2-(tetracosanoylamino)tridec-4-ene-1-sulfonic acid
C37H73NO5S (643.5209167999999)
(E)-3-hydroxy-2-(undecanoylamino)hexacos-4-ene-1-sulfonic acid
C37H73NO5S (643.5209167999999)
(E)-3-hydroxy-2-(pentacosanoylamino)dodec-4-ene-1-sulfonic acid
C37H73NO5S (643.5209167999999)
(E)-2-(docosanoylamino)-3-hydroxypentadec-4-ene-1-sulfonic acid
C37H73NO5S (643.5209167999999)
(E)-2-(heptadecanoylamino)-3-hydroxyicos-4-ene-1-sulfonic acid
C37H73NO5S (643.5209167999999)
(E)-2-(hexadecanoylamino)-3-hydroxyhenicos-4-ene-1-sulfonic acid
C37H73NO5S (643.5209167999999)
(E)-2-(hexacosanoylamino)-3-hydroxyundec-4-ene-1-sulfonic acid
C37H73NO5S (643.5209167999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate
C35H66NO7P (643.4576655999999)
(4E,8E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]tetradeca-4,8-diene-1-sulfonic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] tetradecanoate
C35H66NO7P (643.4576655999999)
3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]nonadecane-1-sulfonic acid
C37H73NO5S (643.5209167999999)
(E)-3-hydroxy-2-(pentadecanoylamino)docos-4-ene-1-sulfonic acid
C37H73NO5S (643.5209167999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] (Z)-tridec-9-enoate
C35H66NO7P (643.4576655999999)
(4E,8E,12E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]icosa-4,8,12-triene-1-sulfonic acid
(E)-3-hydroxy-2-(tetradecanoylamino)tricos-4-ene-1-sulfonic acid
C37H73NO5S (643.5209167999999)
3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]tridecane-1-sulfonic acid
C37H73NO5S (643.5209167999999)
3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]octadecane-1-sulfonic acid
C37H73NO5S (643.5209167999999)
(4E,8E)-2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxydodeca-4,8-diene-1-sulfonic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
C35H66NO7P (643.4576655999999)
(E)-3-hydroxy-2-(tridecanoylamino)tetracos-4-ene-1-sulfonic acid
C37H73NO5S (643.5209167999999)
2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxyhexadecane-1-sulfonic acid
C37H73NO5S (643.5209167999999)
(4E,8E)-2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxyhexadeca-4,8-diene-1-sulfonic acid
2-[[(Z)-hexacos-15-enoyl]amino]-3-hydroxyundecane-1-sulfonic acid
C37H73NO5S (643.5209167999999)
3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]docosane-1-sulfonic acid
C37H73NO5S (643.5209167999999)
3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]heptadecane-1-sulfonic acid
C37H73NO5S (643.5209167999999)
[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C35H66NO7P (643.4576655999999)
[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-undecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C35H66NO7P (643.4576655999999)
2-[4-[12-hydroxy-10,13-dimethyl-3-[(Z)-tridec-9-enoyl]oxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid
2-[4-(10,13-dimethyl-3-tetradecanoyloxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoylamino]acetic acid
4-[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-hexanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]propan-2-yl] octanoate
C35H66NO7P (643.4576655999999)
[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-2-pentanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C35H66NO7P (643.4576655999999)
[2-nonanoyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C35H66NO7P (643.4576655999999)
[2-heptanoyloxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C35H66NO7P (643.4576655999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] dodecanoate
C35H66NO7P (643.4576655999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] (Z)-tetradec-9-enoate
C35H66NO7P (643.4576655999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
C35H66NO7P (643.4576655999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] decanoate
C35H66NO7P (643.4576655999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
C35H66NO7P (643.4576655999999)
(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]dodec-5-enamide
(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadecan-2-yl]tridec-8-enamide
(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexadec-7-enamide
N-(pentadecanoyl)-1-beta-glucosyl-4E-pentadecasphingenine
N-(tridecanoyl)-1-beta-glucosyl-4E-heptadecasphingenine
N-(tetradecanoyl)-1-beta-glucosyl-4E-hexadecasphingenine
N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadec-8-en-2-yl]tridecanamide
N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradec-8-en-2-yl]hexadecanamide
4-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadec-8-en-2-yl]tetradecanamide
2-[[(2S,3R,4E,6E)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxytetradeca-4,6-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2S,3R,4E,8E)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxytetradeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
4-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(E)-dodec-5-enoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-8-en-2-yl]dodecanamide
(E)-N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexadec-9-enamide
4-[2-[(E)-dodec-5-enoyl]oxy-3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(E)-dec-4-enoyl]oxy-2-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2,3-bis[[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxy]propoxy]-2-(trimethylazaniumyl)butanoate
N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicos-8-en-2-yl]decanamide
N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradec-4-en-2-yl]hexadecanamide
4-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(E)-dec-4-enoyl]oxy-3-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadec-8-en-2-yl]pentadecanamide
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(tetradecanoylamino)hexadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]heptadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(pentadecanoylamino)pentadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-(dodecanoylamino)-3-hydroxyoctadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyoctadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-(hexadecanoylamino)-3-hydroxytetradeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxytetradec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(tridecanoylamino)heptadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]hexadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]pentadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E)-2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxytetradeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxynon-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)heptacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-(heptanoylamino)-3-hydroxytricosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]dodec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]dec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(octanoylamino)docosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(nonanoylamino)henicosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-(decanoylamino)-3-hydroxyicosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxytetradec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxytetradeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxytetradecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]undec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxytridec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-acetamido-3-hydroxyoctacosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]dodecoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-(hexanoylamino)-3-hydroxytetracosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxyoct-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(pentanoylamino)pentacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-(butanoylamino)-3-hydroxyhexacosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxyoctoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxytrideca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(undecanoylamino)nonadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]dodeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]heptadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]decoxy]phosphoryl]oxyethyl-trimethylazanium
beta-D-glucosyl-N-(dodecanoyl)sphingosine
A D-glucosyl-N-acylsphingosine in which the ceramide N-acyl group is dodecanoyl.
N-octadecanoylsphingosine 1-phosphate(2-)
C36H70NO6P (643.4940489999999)
A N-acylsphingosine 1-phosphate(2-) in which the N-acyl group is specified as octadecanoyl (stearoyl).
MePC(26:3)
C35H66NO7P (643.4576655999999)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
Hex1Cer(30:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
CerP(36:2)
C36H70NO6P (643.4940489999999)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
[(3r,6r)-6-[(1r,3as,3br,4r,5ar,7s,9as,9bs,11ar)-7-({3-[(4-aminobutyl)amino]propyl}amino)-4-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-3-hydroxy-2-methylheptyl]oxysulfonic acid
C34H65N3O6S (643.4593830000001)
{6-[7-({3-[(4-aminobutyl)amino]propyl}amino)-4,11-dihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methylheptan-3-yl}oxysulfonic acid
C34H65N3O6S (643.4593830000001)
2-[({1-[2-(2-{[2-(dimethylamino)-3-methylpentanoyl]oxy}-n,3-dimethylpentanamido)-3-methylpentanoyl]pyrrolidin-2-yl}(hydroxy)methylidene)amino]-3-phenylpropanimidic acid
C35H57N5O6 (643.4308622000001)
[(3r,6r)-6-[(1r,3as,3br,4r,5ar,7s,9as,9bs,11s,11ar)-7-({3-[(4-aminobutyl)amino]propyl}amino)-4,11-dihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methylheptan-3-yl]oxysulfonic acid
C34H65N3O6S (643.4593830000001)
(2s)-2-({[(2s)-1-[(2s,3s)-2-[(2s,3s)-2-{[(2s,3s)-2-(dimethylamino)-3-methylpentanoyl]oxy}-n,3-dimethylpentanamido]-3-methylpentanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-3-phenylpropanimidic acid
C35H57N5O6 (643.4308622000001)
{6-[7-({3-[(4-aminobutyl)amino]propyl}amino)-4-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-3-hydroxy-2-methylheptyl}oxysulfonic acid
C34H65N3O6S (643.4593830000001)
[(2r,3r,6r)-6-[(1r,3as,3br,4r,5ar,7s,9as,9bs,11ar)-7-({3-[(4-aminobutyl)amino]propyl}amino)-4-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-3-hydroxy-2-methylheptyl]oxysulfonic acid
C34H65N3O6S (643.4593830000001)